Join
Live feed
·
PRReleasevia Quantisnow
Lipella Pharmaceuticals Inc. logo

Lipella Pharmaceuticals Announces Positive Final Results from Phase 2a Study of LP-10 in Oral Lichen Planus

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LIPO (Lipella Pharmaceuticals Inc.) and more on Quantisnow.